A taxonomy for disease management - A scientific statement from the American Heart Association Disease Management Taxonomy Writing Group

被引:201
|
作者
Krumholz, Harlan M.
Currie, Peter M.
Riegel, Barbara
Phillips, Christopher O.
Peterson, Eric D.
Smith, Renee
Yancy, Clyde W.
Faxon, David P.
机构
关键词
AHA Scientific Statements; disease management; chronic disease; delivery of health care; classification; heart failure;
D O I
10.1161/CIRCULATIONAHA.106.177322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Disease management has shown great promise as a means of reorganizing chronic care and optimizing patient outcomes. Nevertheless, disease management programs are widely heterogeneous and lack a shared definition of disease management, which limits our ability to compare and evaluate different programs. To address this problem, the American Heart Association's Disease Management Taxonomy Writing Group developed a system of classification that can be used both to categorize and compare disease management programs and to inform efforts to identify specific factors associated with effectiveness. Methods-The AHA Writing Group began with a conceptual model of disease management and its components and subsequently validated this model over a wide range of disease management programs. A systematic MEDLINE search was performed on the terms heart failure, diabetes, and depression, together with disease management, case management, and care management. The search encompassed articles published in English between 1987 and 2005. We then selected studies that incorporated (1) interventions designed to improve outcomes and/or reduce medical resource utilization in patients with heart failure, diabetes, or depression and (2) clearly defined protocols with at least 2 prespecified components traditionally associated with disease management. We analyzed the study protocols and used qualitative research methods to develop a disease management taxonomy with our conceptual model as the organizing framework. Results-The final taxonomy includes the following 8 domains: (1) Patient population is characterized by risk status, demographic profile, and level of comorbidity. (2) Intervention recipient describes the primary targets of disease management intervention and includes patients and caregivers, physicians and allied healthcare providers, and healthcare delivery systems. (3) Intervention content delineates individual components, such as patient education, medication management, peer support, or some form of postacute care, that are included in disease management. (4) Delivery personnel describes the network of healthcare providers involved in the delivery of disease management interventions, including nurses, case managers, physicians, pharmacists, case workers, dietitians, physical therapists, psychologists, and information systems specialists. (5) Method of communication identifies a broad range of disease management delivery systems that may include in-person visitation, audiovisual information packets, and some form of electronic or telecommunication technology. (6) Intensity and complexity distinguish between the frequency and duration of exposure, as well as the mix of program components, with respect to the target for disease management. (7) Environment defines the context in which disease management interventions are typically delivered and includes inpatient or hospital-affiliated outpatient programs, community or home-based programs, or some combination of these factors. (8) Clinical outcomes include traditional, frequently assessed primary and secondary outcomes, as well as patient-centered measures, such as adherence to medication, self-management, and caregiver burden. Conclusions-This statement presents a taxonomy for disease management that describes critical program attributes and allows for comparisons across interventions. Routine application of the taxonomy may facilitate better comparisons of structure, process, and outcome measures across a range of disease management programs and should promote uniformity in the design and conduct of studies that seek to validate disease management strategies.
引用
收藏
页码:1432 / 1445
页数:14
相关论文
共 50 条
  • [1] An Overview of Telehealth in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association
    Takahashi, Edwin A.
    Schwamm, Lee H.
    Adeoye, Opeolu M.
    Alabi, Olamide
    Jahangir, Eiman
    Misra, Sanjay
    Still, Carolyn H.
    CIRCULATION, 2022, 146 (25) : E558 - E568
  • [2] Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association
    Jone, Pei-Ni
    Tremoulet, Adriana
    Choueiter, Nadine
    Dominguez, Samuel R.
    Harahsheh, Ashraf S.
    Mitani, Yoshihide
    Zimmerman, Meghan
    Lin, Ming-Tai
    Friedman, Kevin G.
    CIRCULATION, 2024, 150 (03) : E481 - E500
  • [3] Management of stroke in infants and children - A scientific statement from a special writing group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the young
    Roach, E. Steve
    Golomb, Meredith R.
    Adams, Robert
    Biller, Jose
    Daniels, Stephen
    deVeber, Gabrielle
    Ferriero, Donna
    Jones, Blaise V.
    Kirkham, Fenella J.
    Scott, R. Michael
    Smith, Edward R.
    STROKE, 2008, 39 (09) : 2644 - 2691
  • [4] Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management A Scientific Statement From the American Heart Association
    Marino, Bradley S.
    Lipkin, Paul H.
    Newburger, Jane W.
    Peacock, Georgina
    Gerdes, Marsha
    Gaynor, J. William
    Mussatto, Kathleen A.
    Uzark, Karen
    Goldberg, Caren S.
    Johnson, Walter H., Jr.
    Li, Jennifer
    Smith, Sabrina E.
    Bellinger, David C.
    Mahle, William T.
    CIRCULATION, 2012, 126 (09) : 1143 - 1172
  • [5] Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease A Scientific Statement From the American Heart Association
    Lui, George K.
    Saidi, Arwa
    Bhatt, Ami B.
    Burchill, Luke J.
    Deen, Jason F.
    Earing, Michael G.
    Gewitz, Michael
    Ginns, Jonathan
    Kay, Joseph D.
    Kim, Yuli Y.
    Kovacs, Adrienne H.
    Krieger, Eric V.
    Wu, Fred M.
    Yoo, Shi-Joon
    CIRCULATION, 2017, 136 (20) : E348 - E392
  • [6] Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart Association
    Shroff, Gautam R.
    Bangalore, Sripal
    Bhave, Nicole M.
    Chang, Tara I.
    Garcia, Santiago
    Mathew, Roy O.
    Rangaswami, Janani
    Ternacle, Julien
    Thourani, Vinod H.
    Pibarot, Philippe
    CIRCULATION, 2021, 143 (25) : E1088 - E1114
  • [7] Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap: A Scientific Statement From the American Heart Association
    Kumar, Raman Krishna
    Antunes, Manuel J.
    Beaton, Andrea
    Mirabel, Mariana
    Nkomo, Vuyisile T.
    Okello, Emmy
    Regmi, Prakash Raj
    Remenyi, Boglarka
    Sliwa-Hahnle, Karen
    Zuhlke, Liesl Joanna
    Sable, Craig
    CIRCULATION, 2020, 142 (20) : E337 - E357
  • [8] Management of Pregnancy in Patients With Complex Congenital Heart Disease A Scientific Statement for Healthcare Professionals From the American Heart Association
    Canobbio, Mary M.
    Warnes, Carole A.
    Aboulhosn, Jamil
    Connolly, Heidi M.
    Khanna, Amber
    Koos, Brian J.
    Mital, Seema
    Rose, Carl
    Silversides, Candice
    Stout, Karen
    CIRCULATION, 2017, 135 (08) : E50 - E87
  • [9] Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association
    Amdani, Shahnawaz
    Conway, Jennifer
    George, Kristen
    Martinez, Hugo R.
    Asante-Korang, Alfred
    Goldberg, Caren S.
    Davies, Ryan R.
    Miyamoto, Shelley D.
    Hsu, Daphne T.
    CIRCULATION, 2024, 150 (02) : e33 - e50
  • [10] Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
    Feinstein, Matthew J.
    Hsue, Priscilla Y.
    Benjamin, Laura A.
    Bloomfield, Gerald S.
    Currier, Judith S.
    Freiberg, Matthew S.
    Grinspoon, Steven K.
    Levin, Jules
    Longenecker, Chris T.
    Post, Wendy S.
    CIRCULATION, 2019, 140 (02) : E98 - E124